Usona Institute
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Psilocybin for Major Depressive Disorder (MDD) (NCT06308653) | Usona Institute | 2024-03-13 |
| Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers (NCT05698095) | Usona Institute | 2022-12-27 |
| An Evaluation of Psilocybin's Effect on Cardiac Repolarization and the Effect of Food on Psilocybin's Pharmacokinetics (NCT05478278) | Usona Institute | 2022-06-22 |
| PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder (NCT04353921) | Usona Institute | 2020-06-30 |
| A Study of Psilocybin for Major Depressive Disorder (MDD) (NCT03866174) | Usona Institute | 2020-01-23 |
Track Usona Institute automatically
Every clearance here is in the API, with alerts when new ones post.